|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
|
BRPI0413018B8
(pt)
*
|
2003-07-30 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, e, uso de um composto
|
|
EP1763514A2
(en)
*
|
2004-05-18 |
2007-03-21 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
GB2420559B
(en)
*
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
EP1814878B1
(en)
*
|
2004-11-24 |
2012-01-04 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
|
DE602006010979D1
(de)
|
2005-01-19 |
2010-01-21 |
Rigel Pharmaceuticals Inc |
Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
US20070203161A1
(en)
*
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
WO2006133426A2
(en)
|
2005-06-08 |
2006-12-14 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
EP1896134A2
(en)
|
2005-06-13 |
2008-03-12 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
|
PL1734251T3
(pl)
*
|
2005-06-17 |
2007-05-31 |
Magneti Marelli Powertrain Spa |
Wtryskiwacz paliwa
|
|
US7713987B2
(en)
*
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
|
CA2642229C
(en)
*
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
EP2089369B1
(en)
|
2006-10-19 |
2011-02-02 |
Rigel Pharmaceuticals, Inc. |
2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
|
|
EP2420505A1
(en)
|
2006-11-21 |
2012-02-22 |
Rigel Pharmaceuticals, Inc. |
Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
|
|
US7947698B2
(en)
|
2007-03-23 |
2011-05-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
WO2008118823A2
(en)
*
|
2007-03-26 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
CA2693594A1
(en)
|
2007-07-17 |
2009-01-22 |
Rigel Pharmaceuticals, Inc. |
Cyclic amine substituted pyrimidinediamines as pkc inhibitors
|
|
CA2714743C
(en)
*
|
2008-02-19 |
2017-01-17 |
Janssen Pharmaceutica N.V. |
Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
|
|
KR101258331B1
(ko)
|
2008-09-11 |
2013-04-26 |
화이자 인코포레이티드 |
헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도
|
|
WO2010084428A1
(en)
|
2009-01-20 |
2010-07-29 |
Pfizer Inc. |
Substituted pyrazinone amides
|
|
MY151246A
(en)
|
2009-03-11 |
2014-04-30 |
Pfizer |
Benzofuranyl derivatives
|
|
CN102470135A
(zh)
*
|
2009-07-28 |
2012-05-23 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
US8906914B2
(en)
|
2009-08-18 |
2014-12-09 |
Janssen Pharmaceutica Nv |
Ethylene diamine modulators of fatty acid hydrolase
|
|
SG181857A1
(en)
|
2009-12-23 |
2012-07-30 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
US8927547B2
(en)
|
2010-05-21 |
2015-01-06 |
Noviga Research Ab |
Pyrimidine derivatives
|
|
PT2576541T
(pt)
|
2010-06-04 |
2016-07-08 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de lrrk2
|
|
HRP20172006T1
(hr)
|
2010-11-10 |
2018-02-09 |
Genentech, Inc. |
Derivati pirazol-aminopiridina kao lrrk2-modulatori
|
|
DK2688883T3
(en)
|
2011-03-24 |
2016-09-05 |
Noviga Res Ab |
pyrimidine
|
|
EP2707357B1
(en)
|
2011-05-10 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
MX2013013090A
(es)
|
2011-05-10 |
2013-12-16 |
Merck Sharp & Dohme |
Aminopirimidinas como inhibidores de tirosina cinaza del bazo.
|
|
JP6026525B2
(ja)
|
2011-06-22 |
2016-11-16 |
武田薬品工業株式会社 |
置換６−アザ−イソインドリン−１−オン誘導体
|
|
EP2763976B1
(en)
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
WO2013052393A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
|
US9487504B2
(en)
|
2012-06-20 |
2016-11-08 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
|
EP2884982B1
(en)
|
2012-08-20 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
WO2014093191A1
(en)
|
2012-12-12 |
2014-06-19 |
Merck Sharp & Dohme Corp. |
AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
|
EP2988744A4
(en)
|
2013-04-26 |
2016-11-02 |
Merck Sharp & Dohme |
THIAZOLSUBSTITUTED AMINOHETEROARYLE AS MILZTYROSINKINASE INHIBITOR
|
|
EP3083560B1
(en)
|
2013-12-20 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9783531B2
(en)
|
2013-12-20 |
2017-10-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9822107B2
(en)
|
2013-12-20 |
2017-11-21 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
WO2015138273A1
(en)
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
CN111233774B
(zh)
*
|
2018-11-28 |
2023-04-14 |
鲁南制药集团股份有限公司 |
一种胺基嘧啶类化合物
|
|
JP2022539208A
(ja)
|
2019-07-03 |
2022-09-07 |
スミトモ ファーマ オンコロジー， インコーポレイテッド |
チロシンキナーゼ非受容体１（ｔｎｋ１）阻害剤およびその使用
|